Search results

Filter (6 in use)

Type 5 selected

  • Remove filter for Guidance (1)
  • Remove filter for NICE advice (1)
  • Remove filter for NICE Pathways (7)
  • Filter by Local practice (2)
  • Remove filter for news
  • Remove filter for quality standards

Status

  • Filter by Published (1)

Last updated 1 selected

  • Filter by Last 3 months
  • Filter by Last 6 months
  • Remove filter for Last year
  • Filter by Last 3 years

Advice programme

  • Filter by Medtech innovation briefings (1)

1 result for ibd

Sorted by Date . | Sort by Relevance

  • Guidance Remove Guidance filter
  • NICE advice Remove NICE advice filter
  • NICE Pathways Remove NICE Pathways filter
  • news Remove news filter
  • quality standards Remove quality standards filter
  • Last year Remove Last year filter
  1. Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)

    NICE has developed a medtech innovation briefing (MIB) on faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection.

    Type
    Medtech innovation briefing
    Published
    02 February 2021